Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of Aripiprazole Once-monthly in Schizophrenia
NCT01959035Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Oct 2013
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aripiprazole in schizophrenia, sponsored by Lundbeck. Started Oct 2013; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01959035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01959035.